Botulinum toxin in urology:
Gespeichert in:
| Hauptverfasser: | , |
|---|---|
| Format: | Buch |
| Sprache: | English |
| Veröffentlicht: |
Berlin ; Heidelberg
Springer
2011
|
| Schlagworte: | |
| Online-Zugang: | Inhaltsverzeichnis |
| Beschreibung: | Literaturangaben |
| Beschreibung: | XVIII, 207 S. Ill., graph. Darst. 24 cm |
| ISBN: | 9783642035807 9783642035791 |
Internformat
MARC
| LEADER | 00000nam a2200000 c 4500 | ||
|---|---|---|---|
| 001 | BV039516437 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | t | ||
| 008 | 110808s2011 ad|| |||| 00||| eng d | ||
| 015 | |a 09,N36,0841 |2 dnb | ||
| 016 | 7 | |a 995947767 |2 DE-101 | |
| 020 | |a 9783642035807 |9 978-3-642-03580-7 | ||
| 020 | |a 9783642035791 |c Pp. : EUR 106.95 (freier Pr.), ca. sfr 202.00 (freier Pr.) |9 978-3-642-03579-1 | ||
| 024 | 3 | |a 9783642035791 | |
| 028 | 5 | 2 | |a 12737536 |
| 035 | |a (OCoLC)750752798 | ||
| 035 | |a (DE-599)DNB995947767 | ||
| 040 | |a DE-604 |b ger |e rakddb | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-29 | ||
| 082 | 0 | |a 616.606 |2 22/ger | |
| 084 | |a 610 |2 sdnb | ||
| 100 | 1 | |a Chancellor, Michael B. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Botulinum toxin in urology |c Michael B. Chancellor ; Christopher P. Smith |
| 264 | 1 | |a Berlin ; Heidelberg |b Springer |c 2011 | |
| 300 | |a XVIII, 207 S. |b Ill., graph. Darst. |c 24 cm | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b n |2 rdamedia | ||
| 338 | |b nc |2 rdacarrier | ||
| 500 | |a Literaturangaben | ||
| 650 | 0 | 7 | |a Urogenitalkrankheit |0 (DE-588)4132473-0 |2 gnd |9 rswk-swf |
| 650 | 0 | 7 | |a Botulinustoxin |0 (DE-588)4273044-2 |2 gnd |9 rswk-swf |
| 655 | 7 | |0 (DE-588)4143413-4 |a Aufsatzsammlung |2 gnd-content | |
| 689 | 0 | 0 | |a Urogenitalkrankheit |0 (DE-588)4132473-0 |D s |
| 689 | 0 | 1 | |a Botulinustoxin |0 (DE-588)4273044-2 |D s |
| 689 | 0 | |5 DE-604 | |
| 700 | 1 | |a Smith, Christopher P. |e Verfasser |4 aut | |
| 776 | 0 | 8 | |i Erscheint auch als |n Online-Ausgabe |t Botulinum Toxin in Urology |
| 856 | 4 | 2 | |m DNB Datenaustausch |q application/pdf |u http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024369032&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |3 Inhaltsverzeichnis |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-024369032 | ||
Datensatz im Suchindex
| _version_ | 1804148322699575296 |
|---|---|
| adam_text | IMAGE 1
CONTENTS
PART I RATIONALE AND SAFETY FOR BONT
1. SAFETY AND GENERAL PRINCIPLES OF BOTULINUM TOXIN THERAPIES: PEARLS
FROM ACROSS MEDICAL FIELDS 3
1.1 INTRODUCTION 3
1.2 CONSIDERATIONS FOR THE SAFE USE OF BONT 3
1.3 GENERAL PRINCIPLES OF BOTULINUM TOXIN THERAPY 6
1.4 AFTER BONT INJECTION PATIENT MANAGEMENT PRINCIPLES 7 1.5 STORAGE AND
DILUTION OF BOTULINUM TOXINS 8
1.5.1 ONABOTULINUMTOXINA (BOTOX) 8
1.5.2 ABOBOTULINUMTOXINA (DYSPORT) 9
1.5.3 RIMABOTULINUMTOXINB (MYOBLOC AND NEUROBLOC) 10 1.5.4
INCOBOTULINUMTOXINA (XEOMIN) 10
1.6 ISSUES IN MULTI-SPECIALTY INTERACTIONS 10
1.7 CONCLUSIONS 11
REFERENCE 11
2. BIOLOGY AND MECHANISM OF ACTION 13
2.1 INTRODUCTION 13
2.2 HISTORY OF MEDICAL BOTULINUM TOXIN 13
2.3 SEVEN SEROTYPES OF BOTULINUM TOXIN 14
2.4 PATHOPHYSIOLOGY 15
2.4.1 FOUR REQUIRED STEPS TO INDUCE PARALYSIS 15
2.5 BONT EFFECT ON MUSCLE NEUROTRANSMISSION 17
2.6 BONT ACTION AT SYNAPSES AND ON NEUROPEPTIDES 18
2.7 BONT ACTION ON URINARY TRACT STRIATED AND SMOOTH MUSCLES 18 2.7.1
EFFERENT EFFECT 19
2.7.2 AFFERENT EFFECT 20
2.7.3 EFFECTS ON ACETYLCHOLINE AND ATP RELEASE 20
2.7.4 EFFECT ON HOT AND COLD SENSITIVE SENSORY RECEPTORS 21 2.7.5
CLINICAL EFFECTS ON CALCITONIN GENE-RELATED PEPTIDE AND SUBSTANCE P
RELEASE 21
2.7.6 INHIBITION OF NERVE GROWTH FACTOR RELEASE AND RECEPTOR TRANSPORT
22
XIII
BIBLIOGRAFISCHE INFORMATIONEN HTTP://D-NB.INFO/995947767
DIGITALISIERT DURCH
IMAGE 2
XIV CONTENTS
2.8 HISTOLOGICAL IMPACT OF BONT INJECTION 22
2.9 BONT ANTIBODY PRODUCTION 23
2.10 CONCLUSION 24
REFERENCES 25
PARTH BLADDER
3. BOTULINUM TOXIN FOR NEUROGENIC DETRUSOR OVERACTIVITY 29 3.1
INTRODUCTION 29
3.2 INDICATIONS 29
3.2.1 SPINAL CORD INJURY 30
3.2.2 MULTIPLE SCLEROSIS: VARIABLE SPECTRUM AND DISEASE PROGRESSION 31
3.2.3 PEDIATRIE NEUROGENIC BLADDERS 32
3.2.4 PARKINSON S DISEASE AND MULTISYSTEM ATROPHY 32 3.3 WHAT IS THE
WORK-UP? 32
3.3.1 HISTORY AND PHYSICAL EXAMINATION 32
3.3.2 URODYNAMIC EVALUATION 33
3.4 HOW TO DO IT 33
3.4.1 PATIENT PREPARATION 33
3.4.2 CYSTOSCOPE 36
3.4.3 BOTULINUM TOXIN RECONSTITUTION 37
3.4.4 DOSE 38
3.4.5 DEPTH, LOCATION, AND AMOUNT OF INJECTION 38
3.4.6 INJECTION TECHNIQUE 39
3.4.7 SIMULTANEOUS BLADDER AND SPHINCTER BONT INJECTION 41 3.4.8
POST-PROCEDURE AND FOLLOW-UP 42
3.4.9 HOW LONG DOES IT LAST AND WHEN IS BOTULINUM TOXIN INJECTION
REPEATED 42
3.4.10 SUBSEQUENT DOSE SELECTION (CAN YOU AND SHOULD YOU GO UP OR DOWN
ON DOSE) 43
3.4.11 RISK OF ANTIBODY FORMATION 43
3.5 WHAT ARE THE RESULTS 44
3.5.1 CLINICAL STUDIES 44
3.5.2 DURATION OF EFFECT 47
3.5.3 REPEAT INJECTIONS 47
3.5.4 NO HISTOLOGICAL DAMAGE TO BLADDER WITH BONT REPEATED INJECTIONS 49
3.5.5 CAN BONT IMPROVE BLADDER COMPLIANCE? 49
3.5.6 ADVERSE EVENTS 52
3.5.7 SIMULTANEOUS BLADDER AND SPHINCTER BONT INJECTION 55 3.6 FUTURE
PERSPECTIVE: ELECTRICAL NEUROMODULATION AND STEM CELL RESEARCH 56
3.7 CONCLUSIONS 57
REFERENCES 57
IMAGE 3
CONTENTS XV
4. OVERACTIVE BLADDER AND IDIOPATHIC DETRUSOR OVERACTIVITY 61 4.1
INTRODUCTION 61
4.2 RATIONALE FOR BONT USE IN IDIOPATHIC OAB 61
4.3 HOW TO DO IT 62
4.3.1 SIMPLIFIED DELIVERY USING FLEXIBLE CYSTOSCOPE 62 4.3.2 DEPTH OF
INJECTION 64
4.4 WHAT ARE THE RESULTS? 68
4.4.1 BOTULIUM TOXIN TYPE A 68
4.4.2 BOTULINUM TOXIN TYPE B 70
4.4.3 PREDICTORS OF POOR RESPONSE 71
4.5 SIDE EFFECTS 72
4.5.1 RISK-BENEFIT RATIO 73
4.6 CONCLUSIONS 76
REFERENCES 76
5. BONT FOR BLADDER AND PELVIC PAIN 79
5.1 INTRODUCTION 79
5.2 INDICATIONS 79
5.3 WHATLS THE WORK-UP 80
5.3.1 HISTORY AND PHYSICAL EXAMINATION 80
5.3.2 URODYNAMIC EVALUATION 80
5.4 HOW TO DO IT 81
5.4.1 PATIENT PREPARATION 81
5.4.2 CYSTOSCOPE 81
5.4.3 BOTULINUM TOXIN RECONSTITUTION 83
5.4.4 DOSE 83
5.4.5 DEPTH, LOCATION, AND AMOUNT OF INJECTION 84
5.4.6 INJECTION TECHNIQUE 84
5.4.7 POST-PROCEDURE AND FOLLOW-UP 85
5.4.8 HOW LONG DOES IT LAST AND WHEN IS BOTULINUM TOXIN INJECTION
REPEATED 85
5.5 WHAT ARE THE RESULTS 85
5.5.1 CLINICAL RESULTS IC/PBS 85
5.5.2 CHRONIC FEMALE PELVIC PAIN SYNDROMES 89
5.5.3 CHRONIC PROSTATIS/MALE CHRONIC PELVIC PAIN SYNDROME (CP/CPPS) 90
5.5.4 RADIATION AND INFLAMMATORY CYSTITIS 90
5.6 CONCLUSIONS 91
REFERENCES 92
6. PEDIATRIE BOTULINUM TOXIN APPLICATIONS 95
6.1 INTRODUCTION 95
6.2 INDICATIONS 96
6.2.1 WHEN TO CONSIDER BOTULINUM TOXIN INJECTION 96 6.2.2 NONNEUROGENIC
INDICATIONS IN CHILDREN 97
6.3 WHAT IS THE WORK-UP? 97
IMAGE 4
XVI CONTENTS
6.3.1 HISTORY AND PHYSICAL EXAMINATION 97
6.3.2 URODYNAMIC EVALUATION 97
6.4 HOW TO DO IT 98
6.4.1 CYSTOSCOPE 98
6.4.2 BOTULINUM TOXIN RECONSTITUTION 99
6.4.3 DOSE 99
6.4.4 DEPTH, LOCATION, AND AMOUNT OF INJECTION 100
6.4.5 INJECTION TECHNIQUE 100
6.4.6 POST-PROCEDURE AND FOLLOW-UP 101
6.5 WHAT ARE THE RESULTS? 101
6.5.1 IDIOPATHIC DETRUSOR OVERACTIVITY CLINICAL STUDIES 104 6.5.2
VOIDING DYSFUNCTION CLINICAL STUDIES 105
6.5.3 REPEAT INJECTION 106
6.6 CONCLUSIONS 106
REFERENCES 107
PART III PROSTATE AND PELVIC FLOOR
7. BOTULINUM TOXIN INJECTION FOR PROSTATE DISORDERS I LL
7.1 INTRODUCTION I LL
7.2 PROSTATE BONT RATIONALE AND MECHANISM OF ACTION 113 7.3 INDICATIONS
115
7.3.1 BPH 115
7.3.2 PROSTATITIS/PROSTATODYNIA 116
7.4 WHAT IS THE WORK-UP? 116
7.4.1 HISTORY AND PHYSICAL EXAMINATION 116
7.5 HOW TO DO IT 117
7.5.1 BPH 117
7.5.2 PROSTATITIS/PROSTATODYNIA 121
7.6 WHAT ARE THE RESULTS? 121
7.6.1 BPH 123
7.6.2 PROSTATITIS/PROSTATODYNIA 126
7.6.3 ADVERSE EVENTS 127
7.7 CONCLUSIONS 128
REFERENCES 128
8. SPHINCTER AND PELVIC FLOOR DISORDERS APPLICATIONS 131
8.1 INTRODUCTION 131
8.1.1 DETRUSOR-SPHINCTER DYSSYNERGIA PATHOLOGY 131 8.2 INDICATIONS 132
8.2.1 NEUROGENIC DSD 132
8.2.2 NON-NEUROGENIC DSD 133
8.2.3 PELVIC FLOOR AND PAIN 134
8.3 WHAT IS THE WORK-UP 134
8.3.1 HISTORY AND PHYSICAL EXAMINATION 134
8.3.2 URODYNAMIC EVALUATION 134
IMAGE 5
CONTENTS XVII
8.4 HOW TO DO IT 137
8.4.1 NEUROGENIC DSD 137
8.4.2 SIMULTANEOUS BLADDER AND SPHINCTER BONT INJECTION 138 8.4.3
NON-NEUROGENIC DSD 138
8.4.4 PELVIC FLOOR AND PAIN 139
8.5 WHAT ARE THE RESULTS 141
8.5.1 NEUROGENIC DSD 142
8.5.2 ADVERSE EVENTS 144
8.5.3 SIMULTANEOUS BLADDER AND SPHINCTER BONT INJECTION 145 8.5.4
NON-NEUROGENIC DSD 145
8.5.5 POST-SURGICAL RETENTION 146
8.5.6 BLADDER NECK DYSSYNERGIA (PRIMARY BLADDER NECK OBSTRUCTION) 147
8.5.7 PELVIC FLOOR AND PAIN 147
8.5.8 PAIN DUE TO HYPERTONIE PELVIC FLOOR MUSCLES 148 8.5.9 VULVODYNIA
149
8.5.10 CHRONIC PROSTATITIS/MALE CHRONIC PELVIC PAIN SYNDROME .. 149 8.6
CONCLUSION 150
REFERENCES 150
PART VI ROLE OF BONT IN MEDICINE
9. NON-UROLOGICAL USES OF TOXIN WITH GENITOURINARY INSIGHT 155 9.1
INTRODUCTION 155
9.2 BONT IN PAIN SYNDROMES 155
9.2.1 BACK PAIN 155
9.2.2 MYOFASCIAL PAIN SYNDROMES 156
9.2.3 HEADACHE AND MIGRAINE 158
9.3 BONT IN THE GASTROINTESTINAL TRACT 159
9.3.1 ACHALASIA 160
9.3.2 CHRONIC ANAL FISSURE 161
9.3.3 EMERGING GASTROINTESTINAL USES OF BONT THERAPY 162 9.4 BONT FOR
HYPERHIDROSIS 163
9.4.1 THERAPEUTIC APPROACHES FOR HYPERHIDROSIS 163 9.4.2 THE ROLE OF
BONT IN HYPERHIDROSIS TREATMENT 163 9.4.3 CLINICAL STUDIES OF BONT:
AXILLARY HYPERHIDROSIS 164 9.4.4 CLINICAL STUDIES OF BONT: PALMAR
HYPERHIDROSIS 165 9.4.5 BONT FOR DROOLING 165
9.5 CONCLUSIONS 166
REFERENCES 166
10. HEALTH ECONOMICS OF BOTULINUM TOXIN APPLICATION 169 10.1
INTRODUCTION 169
10.2 SACRAL NERVE NEUROMODULATION 169
10.2.1 CLINICAL RESULTS WITH SACRAL NERVE NEUROMODULATION 170
IMAGE 6
XVIII CONTENTS
10.3 COMPARATIVE COST ANALYSIS 170
10.3.1 RESULTS 170
10.4 OTHER RECENT REPORTS 172
10.4.1 BONT VERSUS ANTICHOLINERGICS 172
10.4.2 BONT VERSUS AUGMENTATION CYSTOPLASTY 172 10.4.3 DIFFERENT BRANDS
OF BOTULINUM TOXIN 173
10.4.4 BONT COST TO THE FRENCH HEALTH CARE SYSTEM 173 10.4.5 BONT VERSUS
NEW MODALITIES 174
10.5 CONCLUSION 174
REFERENCES 175
11. PERSPECTIVES FROM AROUND THE WORLD: PANORAMA OF WHERE WE ARE AND
WHERE WE ARE GOING 177
11.1 AUSTRALIA: JEFFREY THAVASEELAN 177
11.2 BELGIUM: DIRKDE RIDDER 178
11.3 CANADA: SENDER HERSCHORN 179
11.4 FRANCE: EMMANUEL CHARTIER-KASTLER 180
11.5 GERMANY: TIM SCHNEIDER 181
11.6 INDIAN: SANJAY PANDEY 181
11.6.1 EARLY YEARS OF BONT IN INDIAN UROLOGY (2005-2007) .. 181 11.6.2
THE BONT WONDER YEARS IN INDIAN UROLOGY (2008-2010) 182
11.6.3 CHALLENGES AND DRAFTS FOR FUTURE (2011 - BEYOND) 183 11.7 ITALY:
ANTONELLA GIANNANTONI 183
11.8 JAPAN: YUKIO HOMMA 184
11.9 KOREA: KYU-SUNG LEE 185
11.10 THE NETHERLANDS: JOHN HEESAKKERS 186
11.11 PORTUGAL: FRANCISCO CRUZ 187
11.12 SINGAPORE: MICHAEL WONG 188
11.13 TAIWAN: ALEX T.L. LIN 189
11.14 UNITED KINGDOM: ARUN SAHAI AND PROKAR DASGUPTA 190 11.15 UNITED
KINGDOM UROGYNAECOLOGY : ANGA S. ARUNKALAIVANAN 191
REFERENCES 192
APPENDIX 1 195
APPENDIX 2 199
APPENDIX 3 201
INDEX 205
|
| any_adam_object | 1 |
| author | Chancellor, Michael B. Smith, Christopher P. |
| author_facet | Chancellor, Michael B. Smith, Christopher P. |
| author_role | aut aut |
| author_sort | Chancellor, Michael B. |
| author_variant | m b c mb mbc c p s cp cps |
| building | Verbundindex |
| bvnumber | BV039516437 |
| ctrlnum | (OCoLC)750752798 (DE-599)DNB995947767 |
| dewey-full | 616.606 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.606 |
| dewey-search | 616.606 |
| dewey-sort | 3616.606 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Book |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>01793nam a2200457 c 4500</leader><controlfield tag="001">BV039516437</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">t</controlfield><controlfield tag="008">110808s2011 ad|| |||| 00||| eng d</controlfield><datafield tag="015" ind1=" " ind2=" "><subfield code="a">09,N36,0841</subfield><subfield code="2">dnb</subfield></datafield><datafield tag="016" ind1="7" ind2=" "><subfield code="a">995947767</subfield><subfield code="2">DE-101</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642035807</subfield><subfield code="9">978-3-642-03580-7</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9783642035791</subfield><subfield code="c">Pp. : EUR 106.95 (freier Pr.), ca. sfr 202.00 (freier Pr.)</subfield><subfield code="9">978-3-642-03579-1</subfield></datafield><datafield tag="024" ind1="3" ind2=" "><subfield code="a">9783642035791</subfield></datafield><datafield tag="028" ind1="5" ind2="2"><subfield code="a">12737536</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)750752798</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)DNB995947767</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">rakddb</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-29</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.606</subfield><subfield code="2">22/ger</subfield></datafield><datafield tag="084" ind1=" " ind2=" "><subfield code="a">610</subfield><subfield code="2">sdnb</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Chancellor, Michael B.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Botulinum toxin in urology</subfield><subfield code="c">Michael B. Chancellor ; Christopher P. Smith</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Berlin ; Heidelberg</subfield><subfield code="b">Springer</subfield><subfield code="c">2011</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">XVIII, 207 S.</subfield><subfield code="b">Ill., graph. Darst.</subfield><subfield code="c">24 cm</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">n</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">nc</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Literaturangaben</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Urogenitalkrankheit</subfield><subfield code="0">(DE-588)4132473-0</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="650" ind1="0" ind2="7"><subfield code="a">Botulinustoxin</subfield><subfield code="0">(DE-588)4273044-2</subfield><subfield code="2">gnd</subfield><subfield code="9">rswk-swf</subfield></datafield><datafield tag="655" ind1=" " ind2="7"><subfield code="0">(DE-588)4143413-4</subfield><subfield code="a">Aufsatzsammlung</subfield><subfield code="2">gnd-content</subfield></datafield><datafield tag="689" ind1="0" ind2="0"><subfield code="a">Urogenitalkrankheit</subfield><subfield code="0">(DE-588)4132473-0</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2="1"><subfield code="a">Botulinustoxin</subfield><subfield code="0">(DE-588)4273044-2</subfield><subfield code="D">s</subfield></datafield><datafield tag="689" ind1="0" ind2=" "><subfield code="5">DE-604</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">Smith, Christopher P.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="776" ind1="0" ind2="8"><subfield code="i">Erscheint auch als</subfield><subfield code="n">Online-Ausgabe</subfield><subfield code="t">Botulinum Toxin in Urology</subfield></datafield><datafield tag="856" ind1="4" ind2="2"><subfield code="m">DNB Datenaustausch</subfield><subfield code="q">application/pdf</subfield><subfield code="u">http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024369032&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA</subfield><subfield code="3">Inhaltsverzeichnis</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-024369032</subfield></datafield></record></collection> |
| genre | (DE-588)4143413-4 Aufsatzsammlung gnd-content |
| genre_facet | Aufsatzsammlung |
| id | DE-604.BV039516437 |
| illustrated | Illustrated |
| indexdate | 2024-07-10T00:05:18Z |
| institution | BVB |
| isbn | 9783642035807 9783642035791 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-024369032 |
| oclc_num | 750752798 |
| open_access_boolean | |
| owner | DE-29 |
| owner_facet | DE-29 |
| physical | XVIII, 207 S. Ill., graph. Darst. 24 cm |
| publishDate | 2011 |
| publishDateSearch | 2011 |
| publishDateSort | 2011 |
| publisher | Springer |
| record_format | marc |
| spelling | Chancellor, Michael B. Verfasser aut Botulinum toxin in urology Michael B. Chancellor ; Christopher P. Smith Berlin ; Heidelberg Springer 2011 XVIII, 207 S. Ill., graph. Darst. 24 cm txt rdacontent n rdamedia nc rdacarrier Literaturangaben Urogenitalkrankheit (DE-588)4132473-0 gnd rswk-swf Botulinustoxin (DE-588)4273044-2 gnd rswk-swf (DE-588)4143413-4 Aufsatzsammlung gnd-content Urogenitalkrankheit (DE-588)4132473-0 s Botulinustoxin (DE-588)4273044-2 s DE-604 Smith, Christopher P. Verfasser aut Erscheint auch als Online-Ausgabe Botulinum Toxin in Urology DNB Datenaustausch application/pdf http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024369032&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA Inhaltsverzeichnis |
| spellingShingle | Chancellor, Michael B. Smith, Christopher P. Botulinum toxin in urology Urogenitalkrankheit (DE-588)4132473-0 gnd Botulinustoxin (DE-588)4273044-2 gnd |
| subject_GND | (DE-588)4132473-0 (DE-588)4273044-2 (DE-588)4143413-4 |
| title | Botulinum toxin in urology |
| title_auth | Botulinum toxin in urology |
| title_exact_search | Botulinum toxin in urology |
| title_full | Botulinum toxin in urology Michael B. Chancellor ; Christopher P. Smith |
| title_fullStr | Botulinum toxin in urology Michael B. Chancellor ; Christopher P. Smith |
| title_full_unstemmed | Botulinum toxin in urology Michael B. Chancellor ; Christopher P. Smith |
| title_short | Botulinum toxin in urology |
| title_sort | botulinum toxin in urology |
| topic | Urogenitalkrankheit (DE-588)4132473-0 gnd Botulinustoxin (DE-588)4273044-2 gnd |
| topic_facet | Urogenitalkrankheit Botulinustoxin Aufsatzsammlung |
| url | http://bvbr.bib-bvb.de:8991/F?func=service&doc_library=BVB01&local_base=BVB01&doc_number=024369032&sequence=000001&line_number=0001&func_code=DB_RECORDS&service_type=MEDIA |
| work_keys_str_mv | AT chancellormichaelb botulinumtoxininurology AT smithchristopherp botulinumtoxininurology |